The Food and Drug Administration (FDA) announced the following workshop entitled: “Regulatory Science Considerations for Software Used in Diabetes Management.â€Â The purposes of this workshop were to foster greater stakeholder collaboration in the area of diabetes device interoperability and to seek input form the clinical community, academia, government, industry and other stakeholders regarding the makeup of the intended use population for insulin bolus calculators, and the technical considerations for their design and use.
- Date, Time and Location
- Federal Register Notice
- Webcast
- Agenda
- Registration
- Contact Us
FDA Campus Information
Webcast
[email protected] at least 7 days in advance of the meeting.
[email protected].
For questions regarding workshop content please contact James Mullally or Runa Musib, Office of In Vitro Diagnostics and Radiological Health, Center for Devices and Radiological Health, Food and Drug Administration,
10903 New Hampshire Ave., Bldg. 66 Rm. 5613/5633, Silver Spring, MDÂ 20993, Tel:Â (240) 402-5021/ 301-796-7014, Email:Â [email protected]; [email protected]
[email protected].
10903 New Hampshire Ave., Bldg. 66 Rm. 5613/5633, Silver Spring, MDÂ 20993, Tel:Â (240) 402-5021/ 301-796-7014, Email:Â [email protected]; [email protected]